Stockreport

ERYTECH Reports Top-line Results of Phase 2b Study of Eryaspase for the Treatment of AML

Erytech Pharma S.A. - American Depositary Shares  (ERYP) 
US:NASDAQ Investor Relations: investors.erytech.com
PDF Conference call and webcast to take place Monday, December 11th at 10:00 a.m. EST LYON, France--(BUSINESS WIRE)-- Regulatory News: [Read more]